Cannabidiol increases the nociceptive threshold in a preclinical model of Parkinson's disease (2020)
Source: Neuropharmacology. Unidades: FORP, FMRP
Subjects: CANABINOIDES, NOCICEPTIVIDADE, DOR, DOENÇA DE PARKINSON
ABNT
NASCIMENTO, Glauce Crivelaro do et al. Cannabidiol increases the nociceptive threshold in a preclinical model of Parkinson's disease. Neuropharmacology, v. 163, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.neuropharm.2019.107808. Acesso em: 16 nov. 2024.APA
Nascimento, G. C. do, Ferrari, D. P., Guimarães, F. S., Del Bel, E. A., Bortolanza, M., & Ferreira Junior, N. C. (2020). Cannabidiol increases the nociceptive threshold in a preclinical model of Parkinson's disease. Neuropharmacology, 163. doi:10.1016/j.neuropharm.2019.107808NLM
Nascimento GC do, Ferrari DP, Guimarães FS, Del Bel EA, Bortolanza M, Ferreira Junior NC. Cannabidiol increases the nociceptive threshold in a preclinical model of Parkinson's disease [Internet]. Neuropharmacology. 2020 ; 163[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.neuropharm.2019.107808Vancouver
Nascimento GC do, Ferrari DP, Guimarães FS, Del Bel EA, Bortolanza M, Ferreira Junior NC. Cannabidiol increases the nociceptive threshold in a preclinical model of Parkinson's disease [Internet]. Neuropharmacology. 2020 ; 163[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.neuropharm.2019.107808